Blue Biotechnology | From Gene to Bioactive Product. This item is unavailable.
Language: English
Published by Springer, 2018
Series: Book 28 of 31 - Progress in Molecular and Subcellular Biology
- Softcover
- New



Condition: New
US$ 183.21
Item description from seller
Blue Biotechnology | From Gene to Bioactive Product | Werner E. G. Müller (u. a.) | Taschenbuch | xi | Englisch | 2018 | Springer | EAN 9783319846101 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Seller Inventory # 114227617
- Title
- Blue Biotechnology | From Gene to Bioactive Product
- Author
- Werner E. G. Müller (u. a.)
- Publisher
- Springer
- Publication year
- 2018
- Condition
- Neu
- Binding
- Taschenbuch
- Language
- English
- ISBN 10
- 3319846108
- ISBN 13
- 9783319846101
- Item weight
- 499 grams
- Dimensions
- 235 x 155 x 18 mm
- Series
- Book 28 of 31: Progress in Molecular and Subcellular Biology
- Seller catalogs
- Bücher
This book describes the discovery of molecules from unexploited extreme marine environments, and presents new approaches in marine genomics. It combines the current state of knowledge in marine genomics and advanced natural products’ chemistry to pursue the sustainable production of novel secondary metabolites (lead compounds), as well as pharmacologically active peptides/proteins, with antimicrobial, neuroprotective, anti-osteoporotic, anti-protozoan/anti-plasmodial, anti-ageing and immune-modulating effects. Further, it employs molecular-biology-based approaches and advanced chemical techniques to obtain and to select candidate compounds for pre-clinical and clinical studies.
"Synopsis" may belong to another edition of this title.
From the Back Cover
This book describes the discovery of molecules from unexploited extreme marine environments, and presents new approaches in marine genomics. It combines the current state of knowledge in marine genomics and advanced natural products’ chemistry to pursue the sustainable production of novel secondary metabolites (lead compounds), as well as pharmacologically active peptides/proteins, with antimicrobial, neuroprotective, anti-osteoporotic, anti-protozoan/anti-plasmodial, anti-ageing and immune-modulating effects. Further, it employs molecular-biology-based approaches and advanced chemical techniques to obtain and to select candidate compounds for pre-clinical and clinical studies.
"About the title" may belong to another edition of this title.